Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
NCT04883255Phase 1Completed
- Sponsor
- University of California, San Diego
- Start
- May 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dronabinol and cannabidiol in human immunodeficiency virus infection (HIV) (2 arms), sponsored by University of California, San Diego. Primary endpoints: Iowa Gambling Task at 5 days, Human Temporal Bisection Task at 5 days and 8 more. Started May 2023; status: completed.
02
Drugs
dronabinolcannabidiol
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04883255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04883255.